Science Abstracts
Calcineurin inhibitors for the treatment of atopic dermatitis
September 2010
September 2010
Authors : Jan Ehrchen , Cord Sunderkötter , Thomas Luger , Martin Steinhoff
Affliation : University of Muenster, Boltzmann-Institute for Cell- and Immunobiology of the Skin, Department of Dermatology, 58, Von Esmarch Str, D-48149 Muenster, Germany ; ; Cord.Sunderkoetter@ukmuenster.de
DOI : 10.1517/14656560802498040
Published in : Expert Opin. Pharmacother.
Subject:
Keywords: atopic dermatitis (AD) , calcineurin inhibitor , inflammatory skin disease , pimecrolimus , T cells , tacrolimus
Abstract
Please Login to read the full article.
RELATED CONTENT
NEWS
- GAO: FDA is lax in enforcing Phase IV studies for surrogate endpoint drugs
- Revised US HIV treatment guidelines call for a return to "hit hard, hit early"
- Novartis reports positive data for second fingolimod Phase III study in MS - update
- Hope high for "personalised medicine" in melanoma
ANALYSIS
- Executive Briefing - Getting to grips with advanced therapies in the EU
- Executive Briefing - Battle lines drawn over parallel trade
COMMENT
Other Informa Comment
FEATURES
- Face to face: Ex-Novartis manager takes two-step approach to women's health at Lumavita
- GW high on pipeline of cannabis extracts
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
